Your browser doesn't support javascript.
loading
Bu Shen Yi Sui Capsules Promote Remyelination by Regulating MicroRNA-219 and MicroRNA-338 in Exosomes to Promote Oligodendrocyte Precursor Cell Differentiation.
Ji, Jing; Sun, Ya-Qin; Zha, Zheng; Xue, Bing; Li, Jun-Ling; Jin, Liang-Yun; Qi, Fang; Zhang, Nan; Zhao, Hui; Fan, Yong-Ping; Wang, Lei.
Affiliation
  • Ji J; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Sun YQ; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Zha Z; College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, China.
  • Xue B; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Li JL; Core Facility Center, Capital Medical University, Beijing, China.
  • Jin LY; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Qi F; Core Facility Center, Capital Medical University, Beijing, China.
  • Zhang N; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Zhao H; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Fan YP; School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
  • Wang L; Beijing Tian Tan Hospital, Capital Medical University, Beijing, China.
Article in En | MEDLINE | ID: mdl-35463062

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Evid Based Complement Alternat Med Year: 2022 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Evid Based Complement Alternat Med Year: 2022 Type: Article Affiliation country: China